Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands	9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010
Cash flows from operating activities
Net loss	$ (19,730)	$ (13,055)
Adjustments to reconcile net loss to net cash provided by operating activities:
Noncontrolling Interest	172	91
Depletion, depreciation, and accretion	28,829	7,138
Amortization of deferred financing costs included in interest expense	3,045	861
Gain on sale of assets	(640)	(47)
Cash paid for plugging wells	(8)
Share-based compensation	19,922	5,151
Unrealized (gain) loss on derivative contracts	(17,221)	1,181
Asset impairment		20
Deferred taxes	(470)
Changes in operating assets and liabilities:
Accounts receivable and accrued revenue	(10,426)	1,158
Inventory	(3,006)	70
Prepaid expenses and other current assets	(675)	(502)
Accounts payable	7,968	(1,577)
Revenue payable	1,943	138
Accrued Liabilities	554	3,018
Net cash provided by operating activities	10,257	3,645
Cash flows from investing activities
Capital expenditures and advances	(201,618)	(26,690)
Cash paid in acquisitions, net of cash received of $2.5 million	(78,523)	(59,500)
Change in restricted cash and deposits	(2,837)	(980)
Proceeds from sales of assets	9,459	50
Net cash used in investing activities	(273,519)	(87,120)
Cash flows from financing activities
Net proceeds from sale of common stock and warrants	13,892	24,423
Net proceeds from sale of preferred shares	94,042	22,879
Proceeds from exercise of warrants and options	7,126	13,799
Purchase of company shares and loan to KSOP		(541)
Options surrendered for cash		(116)
Preferred stock dividend paid	(10,017)	(1,335)
Cash paid upon conversion of Series B Preferred Stock		(11,250)
Proceeds from borrowings on debt	408,587	72,580
Principal repayment of debt	(234,047)	(35,779)
Payment of deferred financing costs	(8,528)	(2,630)
Change in other long-term liabilities	59
Net cash provided by financing activities	271,114	82,030
Effect of exchange rate changes on cash	(231)
Net increase (decrease) in cash and cash equivalents	7,621	(1,445)
Cash and cash equivalents, beginning of period	554	2,282
Cash and cash equivalents, end of period	8,175	837
Supplemental disclosure of cash flow information
Cash paid for interest	3,867	1,966
Non-cash transactions
Series B Preferred stock issued for acquisition of Triad		14,982
Debt assumed in acquisitions	71,895	3,411
Common stock issued for payment of services	779	165
Common stock issued in conversion of Series C stock		3,732
Accrued capital expenditures	12,412	10,253
Common stock issued for acquisitions	345,537
Exchangeable common stock issued for acquisition of NuLoch Resources	31,642
Warrants issued for payment of common stock dividends	6,695
Warrants issued for payment of dividends on MHR Exchangeco Corporation exchangeable shares	$ 197